Systems-level reprogramming of PI3K/AKT/mTOR signaling by curcumin and resveratrol: feedback plasticity, metabolic integration, and therapeutic network destabilization in cancer
- 26 June 2026
- journal article
- Published by Springer Nature in Phytochemistry Reviews
- Vol. 25 (7) , 5291-5329
Abstract
No abstract availableKeywords
This publication has 136 references indexed in Scilit:
- Smart nanoparticle delivery systems for curcumin: a targeted strategy to enhance anticancer efficacy and bioavailabilityJournal of Materials Science: Materials in Medicine, 2026
- A review: advances of resveratrol co-delivery biomaterials-based system in anti-tumor therapyJournal of Materials Science: Materials in Medicine, 2025
- Curcumin and Resveratrol as Dual Modulators of the STAT 3 Pathway in Lung Cancer: A Comprehensive ReviewFood Science & Nutrition, 2025
- PI3K/AKT/mTOR Axis in Cancer: From Pathogenesis to TreatmentMedcomm, 2025
- Resveratrol: Molecular Mechanisms, Health Benefits, and Potential Adverse EffectsMedcomm, 2025
- Curcumin's effect in advanced and metastatic breast cancer patients treated with first or second‐line docetaxel: A randomized trialHealth Science Reports, 2024
- Targeting PI3K-gamma in myeloid driven tumour immune suppression: a systematic review and meta-analysis of the preclinical literatureCancer Immunology, Immunotherapy, 2024
- Resveratrol as sensitizer in colorectal cancer plasticityCancer and Metastasis Reviews, 2023
- Curcumin Loaded in Niosomal Nanoparticles Improved the Anti-tumor Effects of Free Curcumin on Glioblastoma Stem-like Cells: an In Vitro StudyMolecular Neurobiology, 2020
- Resveratrol inhibits the proliferation and induces the apoptosis in ovarian cancer cells via inhibiting glycolysis and targeting AMPK/mTOR signaling pathwayJournal of Cellular Biochemistry, 2018